MVGIX
Price
$16.46
Change
-$0.33 (-1.97%)
Updated
Dec 18 closing price
RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
Ad is loading...

MVGIX vs RWIBX

Header iconMVGIX vs RWIBX Comparison
Open Charts MVGIX vs RWIBXBanner chart's image
MFS Low Volatility Global Equity I
Price$16.46
Change-$0.33 (-1.97%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
MVGIX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVGIX vs. RWIBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVGIX is a StrongBuy and RWIBX is a Buy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. MVGIX (269M). MVGIX pays higher dividends than RWIBX: MVGIX (1.33) vs RWIBX (1.05). MVGIX was incepted earlier than RWIBX: MVGIX (11 years) vs RWIBX (23 years). RWIBX is a more actively managed with annual turnover of: 27.00 vs. MVGIX (25.00). MVGIX has a lower initial minimum investment than RWIBX: MVGIX (0) vs RWIBX (250). RWIBX annual gain was more profitable for investors over the last year : 11.34 vs. MVGIX (10.18). RWIBX return over 5 years is better than : 29.64 vs. MVGIX (24.06).
MVGIXRWIBXMVGIX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD8.1569.78183%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets269M121B0%
Annual Yield % from dividends1.331.05127%
Returns for 1 year10.1811.3490%
Returns for 3 years10.588.41126%
Returns for 5 years24.0629.6481%
Returns for 10 years70.9244.22160%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics